| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Licenses | 337.9 | 320.7 | 279.2 | 334.1 | 308.7 | | | 224.6 |
| Other | 519.5 | 446.4 | 416.0 | 401.3 | 322.3 | | | 165.1 |
| Total revenues [+] | 857.4 | 767.1 | 695.2 | 735.4 | 631.0 | 561.6 | 472.0 | 389.8 |
| Licensing | 337.9 | 320.7 | 279.2 | 334.1 | 308.7 | 290.2 | 256.1 | 224.6 |
| Services | 519.5 | 446.4 | 416.0 | 401.3 | 322.3 | 271.3 | 215.9 | 165.1 |
| Revenue growth [+] | 11.8% | 10.3% | -5.5% | 16.5% | 12.4% | 19.0% | 21.1% | 28.1% |
| Licenses | 5.4% | 14.8% | -16.4% | 8.2% | | | | |
| Cost of goods sold [+] | 123.1 | 92.2 | 85.5 | 90.9 | 75.7 | 71.3 | 54.9 | 43.4 |
| Cost of services | 88.4 | 67.8 | 58.5 | 62.1 | 55.2 | 49.8 | 38.4 | 30.5 |
| Cost of licenses/maintenance agreements | | | | 8.6 | 6.1 | 5.6 | 5.0 | 4.0 |
| Cost of licensing | 10.9 | 8.3 | 7.6 | 8.6 | | | | |
| Amortization of intangibles | 23.8 | 16.1 | 19.4 | 20.2 | 14.5 | 15.9 | 11.5 | 8.9 |
| Gross profit | 734.3 | 674.9 | 609.7 | 644.5 | 555.2 | 490.3 | 417.1 | 346.4 |
| Gross margin | 85.6% | 88.0% | 87.7% | 87.6% | 88.0% | 87.3% | 88.4% | 88.9% |
| Selling, general and administrative [+] | 453.6 | 389.7 | 349.7 | 397.4 | 356.8 | 313.3 | 252.3 | 213.3 |
| Sales and marketing | 343.4 | 304.9 | 272.9 | 312.5 | 275.0 | 247.5 | 203.9 | 172.1 |
| General and administrative | 110.2 | 84.8 | 76.7 | 85.0 | 81.8 | 65.8 | 48.4 | 41.1 |
| Research and development | 166.2 | 151.9 | 144.4 | 153.5 | 122.6 | 110.6 | 89.1 | 83.6 |
| Other operating expenses | 24.0 | 12.7 | 13.2 | 11.3 | 7.3 | 2.8 | 7.2 | -8.4 |
| EBITDA [+] | 144.8 | 163.6 | 150.5 | 130.5 | 105.9 | 100.4 | 99.7 | 84.8 |
| EBITDA growth | -11.5% | 8.7% | 15.3% | 23.3% | 5.4% | 0.7% | 17.6% | 61.2% |
| EBITDA margin | 16.9% | 21.3% | 21.6% | 17.8% | 16.8% | 17.9% | 21.1% | 21.7% |
| Depreciation | 14.9 | 14.2 | 15.4 | 37.0 | 30.0 | 30.0 | 23.9 | 21.7 |
| EBITA | 129.9 | 149.4 | 135.1 | 93.6 | 75.9 | 70.4 | 75.8 | 63.1 |
| EBITA margin | 15.2% | 19.5% | 19.4% | 12.7% | 12.0% | 12.5% | 16.1% | 16.2% |
| Amortization of intangibles | 39.4 | 28.8 | 32.6 | 11.3 | 7.3 | 6.8 | 7.2 | 5.2 |
| EBIT [+] | 90.5 | 120.6 | 102.5 | 82.3 | 68.5 | 63.6 | 68.6 | 57.9 |
| EBIT growth | -24.9% | 17.6% | 24.6% | 20.1% | 7.7% | -7.3% | 18.6% | 122.7% |
| EBIT margin | 10.6% | 15.7% | 14.7% | 11.2% | 10.9% | 11.3% | 14.5% | 14.8% |
| Non-recurring items [+] | | | 19.0 | 1.0 | 0.2 | 1.0 | 7.8 | 7.0 |
| Legal settlement | | | 19.0 | | | | | |
| In-process research & development | | | | 1.0 | 0.2 | 1.0 | 7.8 | 7.0 |
| Interest income | 2.1 | 2.4 | 1.9 | | | | | |
| Interest income | 2.1 | 2.4 | 1.9 | | | | | |
| Other income (expense), net [+] | -6.9 | -8.1 | 0.7 | 1.0 | 22.4 | 13.0 | -1.0 | 9.3 |
| Other | -5.4 | -5.6 | 3.3 | 1.0 | 22.4 | 13.0 | | |
| Pre-tax income | 85.7 | 114.9 | 86.0 | 82.4 | 90.7 | 75.7 | 59.7 | 60.2 |
| Income taxes | 33.7 | 16.4 | 15.7 | 14.3 | 27.6 | 16.7 | 27.3 | 7.9 |
| Tax rate | 39.3% | 14.2% | 18.2% | 17.4% | 30.4% | 22.0% | 45.6% | 13.1% |
| Minority interest | -8.1 | | | | | | | |
| Net income | 60.2 | 98.6 | 70.4 | 68.0 | 63.1 | 59.0 | 32.5 | 52.3 |
| Net margin | 7.0% | 12.8% | 10.1% | 9.3% | 10.0% | 10.5% | 6.9% | 13.4% |
| |
| Basic EPS [+] | $0.69 | $1.09 | $0.77 | $0.65 | $0.62 | $0.58 | $0.33 | $0.55 |
| Growth | -36.7% | 42.4% | 17.2% | 5.3% | 6.5% | 75.0% | -39.8% | 136.3% |
| Diluted EPS [+] | $0.68 | $1.06 | $0.75 | $0.64 | $0.60 | $0.57 | $0.32 | $0.53 |
| Growth | -36.0% | 41.3% | 16.8% | 6.8% | 5.8% | 76.4% | -39.8% | 133.9% |
| |
| Shares outstanding (basic) [+] | 87.1 | 90.4 | 91.9 | 104.2 | 101.8 | 101.4 | 97.6 | 94.6 |
| Growth | -3.7% | -1.6% | -11.8% | 2.3% | 0.4% | 3.9% | 3.2% | 2.8% |
| Shares outstanding (diluted) [+] | 89.0 | 93.3 | 94.1 | 106.3 | 105.3 | 104.1 | 101.0 | 97.8 |
| Growth | -4.6% | -0.8% | -11.5% | 0.9% | 1.1% | 3.0% | 3.3% | 3.8% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |